Back to Search
JOSEPH RAJENDRAN, MD
MD
Nuclear Imaging & Therapy Physician
NPI: 1477650943Individual
Specialties, Licenses & Credentials
Nuclear Imaging & Therapy PhysicianPrimary
Nuclear Medicine — Nuclear Imaging & Therapy
Code: 207UN0902X
33369(WA)
Research & Publications (20)
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose.
PMID 18413376·J Nucl Med·2008
4-observational
Beyond detection: novel applications for PET imaging to guide cancer therapy.
PMID 17536105·J Nucl Med·2007
7-preclinical
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.
PMID 17000677·Clin Cancer Res·2006
4-observational
Hypoxia imaging-directed radiation treatment planning.
PMID 16763816·Eur J Nucl Med Mol Imaging·2006
6-review
Expanding role of positron emission tomography in cancer of the uterine cervix.
PMID 16687094·J Natl Compr Canc Netw·2006
6-review
High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.
PMID 15181141·J Nucl Med·2004
3-trial
Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma.
PMID 15665621·Cancer Biother Radiopharm·2004
4-observational
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
PMID 15073099·Clin Cancer Res·2004
8-other
[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.
PMID 12632200·Eur J Nucl Med Mol Imaging·2003
3-trial
High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.
PMID 12368378·J Nucl Med·2002
3-trial
Brain SPECT used to evaluate vasospasm after subarachnoid hemorrhage: correlation with angiography and transcranial Doppler.
PMID 11201469·Clin Nucl Med·2001
8-other
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.
PMID 19515724·Blood·2009
4-observational
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.
PMID 18454687·Cancer Biother Radiopharm·2008
7-preclinical
Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.
PMID 18451225·Clin Cancer Res·2008
8-other
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.
PMID 17312330·J Clin Oncol·2007
8-other
Challenges in clinical studies with multiple imaging probes.
PMID 17921038·Nucl Med Biol·2007
6-review
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.
PMID 17575208·Clin Cancer Res·2007
6-review
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.
PMID 16254140·Blood·2006
3-trial
Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.
PMID 17153406·Med Phys·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- NUCLEAR MEDICINE, BOX 356113, UNIVERITY OF WASHINGTON, 1959 NE PACIFIC STREET
SEATTLE, WA 98195 - Phone
- (206) 221-4421
Quick Facts
- NPI
- 1477650943
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile